Association of Interleukin 8 and Myocardial Recovery in Patients with ST-Elevation Myocardial Infarction Complicated by Acute Heart Failure

被引:35
|
作者
Husebye, Trygve [1 ,3 ,4 ]
Eritsland, Jan [1 ,3 ]
Arnesen, Harald [2 ,3 ,4 ]
Bjornerheim, Reidar [1 ,3 ]
Mangschau, Arild [1 ,3 ]
Seljeflot, Ingebjorg [1 ,2 ,3 ,4 ]
Andersen, Geir Oystein [1 ,2 ,3 ]
机构
[1] Univ Oslo, Hosp Ulleval, Dept Cardiol, Oslo, Norway
[2] Univ Oslo, Hosp Ulleval, Ctr Clin Heart Res, Oslo, Norway
[3] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway
[4] Univ Oslo, Fac Med, Oslo, Norway
来源
PLOS ONE | 2014年 / 9卷 / 11期
关键词
PERCUTANEOUS CORONARY INTERVENTION; CYTOKINE LEVELS; LEVOSIMENDAN; DYSFUNCTION; RECEPTORS; TRIAL;
D O I
10.1371/journal.pone.0112359
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: No data from controlled trials exists regarding the inflammatory response in patients with de novo heart failure (HF) complicating ST-elevation myocardial infarction (STEMI) and a possible role in the recovery of contractile function. We therefore explored the time course and possible associations between levels of inflammatory markers and recovery of impaired left ventricular function as well as levosimendan treatment in STEMI patients in a substudy of the LEvosimendan in Acute heart Failure following myocardial infarction (LEAF) trial. Methods: A total of 61 patients developing HF within 48 hours after a primary PCI-treated STEMI were randomised double-blind to a 25 hours infusion of levosimendan or placebo. Levels of IL-6, CRP, sIL-6R, sgp130, MCP-1, IL-8, MMP-9, sICAM-1, sVCAM-1 and TNF-alpha were measured at inclusion (median 22 h, interquartile range (IQR) 14, 29 after PCI), on day 1, day 2, day 5 and 6 weeks. Improvement in left ventricular function was evaluated as change in wall motion score index (WMSI) by echocardiography. Results: Only circulating levels of IL-8 at inclusion were associated with change in WMSI from baseline to 6 weeks, r = divided by 0.41 (p = 0.002). No association, however, was found between IL-8 and WMSI at inclusion or peak troponin T. Furthermore, there was a significant difference in change in WMSI from inclusion to 6 weeks between patients with IL-8 levels below, compared to above median value, divided by 0.44 (IQR divided by 0.57, divided by 0.19) vs. divided by 0.07 (IQR divided by 0.27, 0.07), respectively (p<0.0001). Levosimendan did not affect the levels of inflammary markers compared to control. Conclusion: High levels of IL-8 in STEMI patients complicated with HF were associated with less improvement in left ventricular function during the first 6 weeks after PCI, suggesting a possible role of IL-8 in the reperfusion-related injury of post-ischemic myocardium. Further studies are needed to confirm this hypothesis.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Completeness of Revascularization in Patients With ST-Elevation Acute Myocardial Infarction
    Kornowski, Ran
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2008, 72 (07) : 934 - 936
  • [22] Patient Delay in Patients With ST-elevation Acute Myocardial Infarction
    郭金成
    华琦
    刘东霞
    许敏
    许骥
    李东宝
    South China Journal of Cardiology, 2007, (01) : 12 - 16
  • [23] Risk assessment in patients with an acute ST-elevation myocardial infarction
    Ahmed, Nadeem
    Carberry, Jaclyn
    Teng, Vannesa
    Carrick, David
    Berry, Colin
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (06) : 581 - 593
  • [24] Effect of Postconditioning in Patients with ST-Elevation Acute Myocardial Infarction
    Ugata, Yusuke
    Nakamura, Tomohiro
    Kobori, Takako
    Taniguchi, Yosuke
    Ako, Junya
    Momomura, Shinichi
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 2B - 2B
  • [25] Fondaparinux in the management of patients with ST-elevation acute myocardial infarction
    Turpie, Alexander G. G.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (04) : 371 - 378
  • [26] Effect of postconditioning in patients with ST-elevation acute myocardial infarction
    Yusuke Ugata
    Tomohiro Nakamura
    Yousuke Taniguchi
    Junya Ako
    Shinichi Momomura
    Cardiovascular Intervention and Therapeutics, 2012, 27 (1) : 14 - 18
  • [27] Temporal Trends in Outcomes of ST-Elevation Myocardial Infarction Patients With Heart Failure and Diabetes
    Ali, Bassem
    Dargham, Soha
    Al Suwaidi, Jassim
    Jneid, Hani
    Abi Khalil, Charbel
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [28] Health care system delay and heart failure in patients with ST-elevation myocardial infarction
    Terkelsen, C. J.
    Jensen, L. O.
    Tilsted, H. H.
    Trautner, S.
    Johnsen, S. P.
    Vach, W.
    Boetker, H. E.
    Thuesen, L.
    Lassen, J. F.
    EUROPEAN HEART JOURNAL, 2011, 32 : 236 - 236
  • [29] Effect of postconditioning in patients with ST-elevation acute myocardial infarction
    Ugata, Yusuke
    Nakamura, Tomohiro
    Taniguchi, Yousuke
    Ako, Junya
    Momomura, Shinichi
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2012, 27 (01) : 14 - 18
  • [30] COVID-19 infection complicated by acute ST-elevation myocardial infarction
    Fu, Tianyuan
    Mamaliga, Galina
    Pierce, Jonathan D.
    Gilkeson, Robert
    Gupta, Amit
    Fu, Tianyuan (tianyuan.fu@uhhospitals.org), 1600, Elsevier Inc. (78): : 117 - 120